Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr ...

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its digital pathology portfolio with new cloud-enabled capabilities designed to help ...

Philips has expanded its digital pathology portfolio with the launch of a fully cloud-enabled version of its IntelliSite Pathology solution. The system, built on Amazon Web Services, is designed to ...

The new facility offers a crucial resource for those seeking definitive answers regarding cause of death, medical ...

The latest milestone follows PathAI’s 510(k) clearance for AISight Dx, the first FDA-approved digital pathology system.

Artificial intelligence could make cancer diagnosis safer and fairer by learning when to defer to human pathologists without overloading them, according to researchers from the University of Surrey ...

March 11, 2026 Fully cloud- enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows Amsterdam, The Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA) ...

GLENDALE, CA - March 16, 2026 - LigoLab, a laboratory informatics company headquartered in Glendale, reported key ...

Implementing Digital pathology and AI in cancer diagnosis alleviates impact of pathologist shortage through improved workflow and remote collaboration capabilities ...

Ghaffar, oversaw the signing of a memorandum of understanding on Sunday to launch a national digital pathology network ...

Psychoanalysis was at its zenith in the middle of last century. Since then, the field has been on the outskirts of psychiatry ...

PathAI, Inc., a global leader in artificial intelligence (AI)-powered pathology solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation ...